Regenerex Pharma (RGPX) Non Operating Income (2019 - 2025)
Regenerex Pharma (RGPX) reported Non Operating Income of -$27302.0 for Q3 2025, up 89.93% year-over-year from -$14374.6 in Q3 2024, and up 8.39% on a QoQ basis from -$29801.0 in Q2 2025.
Regenerex Pharma (RGPX) has 7 years of Non Operating Income data on file, last reported at -$27302.0 in Q3 2025.
- Quarterly Non Operating Income rose 89.93% year-over-year to -$27302.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$468580.0 (down 43.5% YoY) and the FY2025 annual result came in at -$700944.0, down 798.62% from the prior year.
- Non Operating Income grew to -$27302.0 in Q3 2025 per RGPX's latest filing, from -$29801.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $3068.0 in Q3 2022 and bottomed at -$408461.0 in Q1 2025.
- The 5-year median for Non Operating Income is -$18145.5 (2023), against an average of -$52279.1.
- The widest annual swing landed in 2021, when Non Operating Income slumped 6061.05%; it then surged 130.02% in 2022.
- Tracing RGPX's Non Operating Income over 5 years: stood at -$16437.0 in 2021, then dropped by 23.49% to -$20298.0 in 2022, then decreased by 21.15% to -$24592.0 in 2023, then surged by 87.74% to -$3016.0 in 2024, then plunged by 805.24% to -$27302.0 in 2025.
- Per Business Quant, the three latest RGPX Non Operating Income figures stand at -$27302.0 (Q3 2025), -$29801.0 (Q2 2025), and -$408461.0 (Q1 2025).
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -27,302.00 |
| Jun 30, 2025 | -29,801.00 |
| Mar 31, 2025 | -408,461.00 |
| Dec 31, 2024 | -3,016.00 |
| Sep 30, 2024 | -271,188.00 |
| Jun 30, 2024 | -18,280.00 |
| Mar 31, 2024 | -12,483.00 |
| Dec 31, 2023 | -24,592.00 |
| Sep 30, 2023 | -15,526.00 |
| Jun 30, 2023 | -25,401.00 |
| Mar 31, 2023 | -18,011.00 |
| Dec 31, 2022 | -20,298.00 |
| Sep 30, 2022 | 3,068.00 |
| Jun 30, 2022 | -5,919.00 |
| Mar 31, 2022 | -20,167.00 |
| Dec 31, 2021 | -16,437.00 |
| Sep 30, 2021 | -10,221.00 |
| Jun 30, 2021 | -16,989.00 |
| Dec 31, 2020 | -19,431.00 |
| Sep 30, 2020 | -13,813.00 |
| Jun 30, 2020 | 285.00 |
| Mar 31, 2020 | -18,664.00 |
| Dec 31, 2019 | -7,926.00 |
| Sep 30, 2019 | -6,848.00 |
| Jun 30, 2019 | -1,147.00 |